C5AR2 and Sepsis: In view of the lack of highly effective drugs for the treatment of human sepsis, the expanding evidence suggests the possible roles of the complement activation product, C5a, and its receptors (C5aR and C5L2) as targets in the highly damaging and lethal consequences of sepsis.